PTEN and breast carcinoma: The NEDD4-1-PTEN axis is implicated in the progression of non-small-cell lung cancer, breast cancer, glioblastoma, prostate cancer, pituitary adenoma, pancreatic ductal adenocarcinoma, bladder cancer, melanoma, and gastric cancer.